Relative Survival Benefit and Morbidity with Fluids in Severe Sepsis - A Network Meta-Analysis of Alternative Therapies

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|8|4|236-245

ISSN： 1574-8863

Source： Current Drug Safety, Vol.8, Iss.4, 2013-01, pp. : 236-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 454-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta‐analysis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 4, 2015-04 ,pp. : 508-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of interferon‐free therapies for chronic hepatitis C: a network meta‐analysis

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 478-485

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antithrombin III: no benefit in severe sepsis

By  

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride

By Gupta Aditya K   Charrette Andrew  

Journal of Dermatological Treatment, Vol. 25, Iss. 2, 2014-04 ,pp. : 156-161

Informa Healthcare

Access to resources Recommend Favorite